Lip and Oral Cavity Cancer, also known as lip and oral cavity carcinoma, is related to oral cancer and oral cavity cancer. An important gene associated with Lip and Oral Cavity Cancer is CDKN2A (Cyclin Dependent Kinase Inhibitor 2A), and among its related pathways/superpathways are Infectious disease and Signal Transduction. The drugs Pembrolizumab and Paclitaxel have been mentioned in the context of this disorder. Affiliated tissues include tongue and lymph node, and related phenotypes are Decreased viability and Decreased substrate adherent cell growth